NCT02665364
Study of IFN-K in Systemic Lupus Erythematosus
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Sponsor: Neovacs
Phase 2

